Transfer (PNT) fertilised with technique sperm in a lab (substitute to to create MST) embryos. The nuclear genetic material within each embryo is then transferred into embryos created using donated eggs and sperm from the sperm provider. Again, the nuclear genetic material will have been removed from the donated eggs. Benefits of Mitochondrial Donation Treatment (MDT) • Disease Prevention: As there are no Ethical concerns associated with MDTs effective treatments for mitochondrial • Potential for 'Designer Babies': As MDTs involve genetic modification, diseases that can cause severe health they could potentially open the door to the creation of "designer babies" - embryos genetically engineered for preferred characteristics. issues, MDT offers a chance for a healthier o This brings up a multitude of ethical concerns related to eugenics life for a baby. and potential misuse of the technology. o About one in 6,000 babies are o Eugenics refers to the selection of desired heritable affected by mitochondrial disorder. characteristics in order to improve future generations, typically in • Genetic Connection: MRT can assist older reference to humans. women with poor quality eggs to have a • Issue of Mitochondrial Donor's role in child’s life: The donor play’s a biologically related child by retaining the significant role in child’s healthy conception, but their contribution is woman's nuclear DNA while using limited to the initial stage. mitochondria from a younger donor. o This creates ambiguity vis-à-vis donor’s biological claim on the child or involvement in their life.
• Reproductive Freedom: MRT can benefit same-sex female couples seeking a child genetically related to both, with one woman providing nuclear DNA and the other providing mitochondrial DNA. Issues with Mitochondrial Donation Treatment: • Effectiveness Concerns: The dynamic nature of mitochondria and potential residual damaged mitochondria after transfer could compromise MRT's effectiveness and long-term benefits. • Incompatibility Risks: Potential incompatibility between donor's mitochondria and receiver's nuclear genome could pose challenges. • Lack of Data: MRT is in its experimental stages with inadequate data on potential adverse effects, making careful application critical. • Impact on Child: There are concerns that MRT could influence a child's personality, including potential neurological changes, and pose risks such as developmental disability and increased cancer risk. • Cost Barriers: MRT is a costly procedure, making it inaccessible to many sections of society. Conclusion If MDT technique is to be implemented in the country, there should be a regulatory body that governs its usage to avoid any unethical practises. Proper clinical trials are the need of the hour for data to be collected on the safety and efficacy of the technique being used.
7.2. ANTIMICROBIAL RESISTANCE (AMR)
Why in News? Recently, WHO in partnership with the Global AMR R&D Hub, has released ‘Incentivizing the development of New Antibacterial Treatments 2023’ Report. More about News • Report is for the G7 countries monitoring and handling of AMR. • About Global AMR R&D Hub o It is a partnership of countries, non- governmental donor organizations and intergovernmental organizations. o It was launched in 2018, to address challenges and improve coordination and collaboration in global AMR R&D using a One Health approach.